|
|
Mike Hayes
Extensive experience with GSK and biotechnology companies including Biotica.
Keith Powell
CEO; extensive experience in the management of large and small biotech companies. Led SPEAR into an $8.5M series B financing round.
Tony Brampton
Almost 20 years investment in bioscience and other areas. Investment management ex-Managing Director JP Morgan Cazenove.
Till Medinger
President, ABPI (1994-1996); extensive international pharmaceutical industry experience (Board level) in territorial and marketing management, external and government affairs.
Stephane Mery
Fund Manager of the Bloomsbury Bioseed Fund and a Director of Healthcare Investment at Noble Fund Manager. Previously Associate Director, Worldwide Business Development, for SmithKline Beecham.
Steve Brocchini
CSO, co-founder of PolyTherics; currently Professor at London School of Pharmacy.
|
|
Sitemap | Privacy Policy | Terms of Use
